ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >PI3K / Akt / mTOR >AMPK inhibitor >BML-275

BML-275

BML-275 Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: CAS:1219168-18-9
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G.100G
Company Name: Hubei Jusheng Technology Co.,Ltd.
Tel: 18871490254
Email: linda@hubeijusheng.com
Products Intro: Product Name:BML-275
CAS:1219168-18-9
Purity:0.99 Package:5KG;1KG
Company Name: BOC Sciences
Tel: +1-631-485-4226
Email: inquiry@bocsci.com
Products Intro: Product Name:Dorsomorphin 2HCl
CAS:1219168-18-9
Package:500mg Remarks:BOC Sciences also provides custom synthesis services for Dorsomorphin 2HCl.
Company Name: Tianjin Xinshengjiahe Science & Technology Development Co,.Ltd
Tel: +86-86-22-87899925 +86-8618522618860
Email: 18522618860@163.com
Products Intro: Product Name:BML-275 dihydrochloride
CAS:1219168-18-9
Purity:0.99 Package:Various Packaging; segregation
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel: 86-571-88216897,88216896 13588875226
Email: sales@hzclap.com
Products Intro: Product Name:Dorsomorphin dihydrochloride
CAS:1219168-18-9
Purity:26299% Package:10kg 25kg 200 kilograms per barrel Remarks:good
BML-275 Basic information
Product Name:BML-275
Synonyms:Dorsomorphin 2HCl (BML-275 2HCl);dorsoMorphin (Hydrochloride);DorsoMorphin, Dihydrochloride Salt, >99%;BML-275,Compound C;6-[4-[2-(1-Piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)pyrazolo[1,5-a]pyrimidine hydrochloride (1:2) Dorsomorphin 2HCl;Dorsomorphin-2HCl BML-275;6-[4-[2-(1-Piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)pyrazolo[1,5-a]pyrimidine hydrochloride (1:2);BML-275 dihydrochloride
CAS:1219168-18-9
MF:C24H27Cl2N5O
MW:472.41008
EINECS:
Product Categories:PI3K/Akt/mTOR;Inhibitors;Akt;mTOR;PI3K
Mol File:1219168-18-9.mol
BML-275 Structure
BML-275 Chemical Properties
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
solubility insoluble in EtOH; insoluble in H2O; ≥11.34 mg/mL in 0.9% NS ; ≥39.93 mg/mL in DMSO:H2O=2:1 ; ≥5.91 mg/mL in DMSO
form Light yellow powder solid.
color Yellow
Stability:Hygroscopic
Safety Information
MSDS Information
BML-275 Usage And Synthesis
DescriptionDorsomorphin (hydrochloride) is a potent, reversible inhibitor of AMP kinase (AMPK; Ki = 109 nM) that does not exhibit significant activity on structurally related kinases, including ZAPK, SYK, PKCθ, PKA, and JAK3. Dorsomorphin can also dose-dependently inhibit the bone morphogenetic protein type 1 receptors ACTR-I (ALK2), BMPR-IA (ALK3), and BMPR-IB (ALK6). Independent of AMPK inhibition, dorsomorphin, at 10 μM, has additionally been shown to downregulate the Akt/mTOR pathway to induce autophagy in U251 human glioma cells.
UsesDorsomorphin is an AMP-activated kinase (AMPK) inhibitor. Dorsomorphin selectively inhibits the bone morphogenetic protein (BMP) type I receptors ALK2, ALK3 and ALK6 and thus blocks BMP-mediated SMAD1/5/8 phosphorylation, target gene transcription and osteogenic differentiation. Dorsomorphin has shown to increase cisplatin-induced apoptosis, which was associated with hyper-induction of the tumor suppressor p53.
storageRoom temperature (desiccate)
BML-275 Preparation Products And Raw materials
Tag:BML-275(1219168-18-9) Related Product Information
D-ERYTHRO-SPHINGOSINE 3-METHYLADENINE SB 431542 A 769662 AICAR LY 294002 HYDROCHLORIDE Rapamycin KU-55933 Selumetinib PLX-4720 CX-4945 Fluoxetine hydrochloride Alpelisib (BYL719) Tubastatin A hydrochloride N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide hydrochloride BI 2536 Neratinib Glucagon Receptor Antagonist I